IDStewardship

JUNE 19, 2025

Despite advancements in treatment, certain patients may exhibit delayed responses, have drug-resistant TB, be at risk for drug-drug interactions, or have comorbid conditions that considerably complicate clinical management. 17 (2017), pp. Sanchez Garavito, D. Vargas Vasquez, C.D. Mitnick, G. Agents Chemother. 61, 10.1128/AAC.00038-17

HIV Treatment and Prevention Agents 130

HIV Treatment and Prevention Agents Adverse Reactions Dosage Labelling 130

IDStewardship

JULY 27, 2022

In 2017 I volunteered as a disaster relief pharmacist for a non-governmental organization. I worked in Sierra Leone for four months at an Ebola treatment centre, followed by a brief time in Nepal after the 2017 earthquake. In hospitals, there is a target to reduce WHO watch and reserve antibiotics by 10% compared to 2017 levels.

Hospitals 147

Hospitals Clinic Management Labelling Vaccines 147

ISPE

OCTOBER 27, 2022

There are important considerations if the DHTT is classified as a medical device, which may change the level of regulatory controls and evidentiary requirements to support its appropriate use, such as off-label versus on-label use of a device with prior marketing authorization. IMDRF SaMD Risk Categorization. Framework 26.

Health and Personal Care Stores 52

Health and Personal Care Stores FDA Communication Clinic Management 52

ISPE

OCTOBER 27, 2022

There are important considerations if the DHTT is classified as a medical device, which may change the level of regulatory controls and evidentiary requirements to support its appropriate use, such as off-label versus on-label use of a device with prior marketing authorization. IMDRF SaMD Risk Categorization. Framework 26.

Health and Personal Care Stores 52

Health and Personal Care Stores FDA HIPAA Communication 52